Author Archives: Myriam Ouberai

Venture Voices: Myriam Ouberai, Founder of Spirea

Venture Voices: Myriam Ouberai, Founder of Spirea

I am Myriam Ouberai, CEO and Founder of Spirea. Our venture has developed an exciting and flexible new approach to building antibody drug conjugate (ADC) cancer therapeutics that allows more drug payload to be specifically directed to tumour cells. This results in an increase in the therapeutic window and improved efficacy. By delivering the right… Read more